The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Urinary Tract Infections: Current and Emerging Management Strategies
Open accessAbstract
Acute cystitis is one of the most commonly encountered bacterial infections and is responsible for substantial morbidity and high medical costs in the United States and across the globe. Though generally considered to be self-limiting and easily treated with antibiotics, urinary tract infections (UTIs) are often incompletely resolved by antibiotic therapy and frequently recur. This is in part due to the ability of uropathogenic bacteria to invade, replicate, and persist within host epithelial cells. The biological complexity of these infections combined with a dramatic rise in antibiotic-resistant pathogens highlight the need for alternative therapies. In this review we examine current management strategies for UTIs, as well as emerging treatments, including novel compounds that block bacterial interactions with the urothelium and vaccines focused on preventing both acute and recurrent infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Type 1 pilus-mediated bacterial invasion of bladder epithelial cells
Martinez, J. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2803 · Cited by 758
The etiology of urinary tract infection: traditional and emerging pathogens
Ronald, A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01055-0 · Cited by 665
Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection
Rosen, D. A., Hooton, T. M., Stamm, W. E., Humphrey, P. A., & Hultgren, S. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040329 · Cited by 651 · cited 2×
“from women seeking treatment for UTIs [3].”
BackgroundJustice, S. S., Hung, C., Theriot, J. A., Fletcher, D. A., Anderson, G. G., Footer, M. J., & Hultgren, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308125100 · Cited by 632
Origins and virulence mechanisms of uropathogenic Escherichia coli
Wiles, T. J., Kulesus, R. R., & Mulvey, M. A. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.03.007 · Cited by 606
Self-citationPrevention of Mucosal Escherichia coli Infection by FimH-Adhesin-Based Systemic Vaccination
Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J. S., Burlein, J., Barren, P., Koenig, S., Leath, S., Jones, C. H., et al. (1997) · Science · doi:10.1126/science.276.5312.607 · Cited by 577
Peirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443 · cited 3×
“quisition of antibiotic resistance genes, such as those encoding extended-spectrum β-lactamases (ESBLs), and the capacity to effectively utilize a broad range of metabolites [8, 10].”
BackgroundThe Diagnosis of Urinary Tract Infection
Schmiemann, G., Kniehl, E., Gebhardt, K., Matejczyk, M. M., & Hummers-Pradier, E. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0361 · Cited by 440
He, Y., Xiang, Z., & Mobley, H. L. T. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/297505 · Cited by 355
Langermann, S., Möllby, R., Burlein, J. E., Palaszynski, S. R., Auguste, C. G., DeFusco, A., Strouse, R., Schenerman, M. A., Hultgren, S. J., Pinkner, J. S., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315258 · Cited by 336
Wright, K. J., Seed, P. C., & Hultgren, S. J. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00952.x · Cited by 334
Persistence of Uropathogenic Escherichia coli in the Face of Multiple Antibiotics
Blango, M. G., & Mulvey, M. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00014-10 · Cited by 328
Self-citationTreatment and Prevention of Urinary Tract Infection with Orally Active FimH Inhibitors
Cusumano, C. K., Pinkner, J. S., Han, Z., Greene, S. E., Ford, B. A., Crowley, J. R., Henderson, J. P., Janetka, J. W., & Hultgren, S. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003021 · Cited by 318
Urinary Tract Infections in Women
Dielubanza, E. J., & Schaeffer, A. J. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.08.023 · Cited by 311
Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria
Pinkner, J. S., Remaut, H., Buelens, F., Miller, E., Åberg, V., Pemberton, N., Hedenström, M., Larsson, A., Seed, P., Waksman, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606795103 · Cited by 301
Moriel, D. G., Bertoldi, I., Spagnuolo, A., Marchi, S., Rosini, R., Nesta, B., Pastorello, I., Corea, V. A. M., Torricelli, G., Cartocci, E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915077107 · Cited by 261
Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH Antagonists
Han, Z., Pinkner, J. S., Ford, B., Obermann, R., Nolan, W., Wildman, S. A., Hobbs, D., Ellenberger, T., Cusumano, C. K., Hultgren, S. J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100438s · Cited by 236
Klein, T., Abgottspon, D., Wittwer, M., Rabbani, S., Herold, J., Jiang, X., Kleeb, S., Lüthi, C., Scharenberg, M., Bezençon, J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101011y · Cited by 206
Mucosal Immunization with Iron Receptor Antigens Protects against Urinary Tract Infection
Alteri, C. J., Hagan, E. C., Sivick, K. E., Smith, S. N., & Mobley, H. L. T. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000586 · Cited by 201
The etiology of urinary tract infection: Traditional and emerging pathogens
Ronald, A. (2003) · Disease-a-Month · doi:10.1016/s0011-5029(03)90001-0 · Cited by 193
Thanassi, D. G., Bliska, J. B., & Christie, P. J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00342.x · Cited by 172
Pitout, J. D. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.110 · Cited by 161
Covert Operations of Uropathogenic Escherichia coli within the Urinary Tract
Bower, J. M., Eto, D. S., & Mulvey, M. A. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00251.x · Cited by 152
Self-citationThankavel, K., Madison, B. M., Ikeda, T., Malaviya, R., Shah, A. H., Arumugam, P. M., & Abraham, S. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119623 · Cited by 146
Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli
Eto, D. S., Sundsbak, J. L., & Mulvey, M. A. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00691.x · Cited by 145
Self-citationGenetics of innate immunity and UTI susceptibility
Ragnarsdóttir, B., Lutay, N., Grönberg-Hernández, J., Köves, B., & Svanborg, C. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.100 · Cited by 136
Hopkins, W. J., Elkahwaji, J. E., Beierle, L. M., LEVERSON, G. E., & Uehling, D. T. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.11.093 · Cited by 135
Current concepts of molecular defence mechanisms operative during urinary tract infection
Weichhart, T., Haidinger, M., Hörl, W. H., & Säemann, M. D. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02006.x · Cited by 134
Guiton, P. S., Cusumano, C. K., Kline, K. A., Dodson, K., Han, Z., Janetka, J. W., Henderson, J. P., Caparon, M. G., & Hultgren, S. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00447-12 · Cited by 119
Acute Pyelonephritis Among Adults
Brown, P. D., Ki, M., & Foxman, B. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523110-00005 · Cited by 117
Phase 2 Clinical Trial of a Vaginal Mucosal Vaccine for Urinary Tract Infections
Uehling, D. T., Hopkins, W. J., Elkahwaji, J. E., SCHMIDT, D., & LEVERSON, G. E. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000075094.54767.6e · Cited by 117
Diagnosis and treatment of acute pyelonephritis in women.
Colgan, R., Williams, M., & Johnson, J. R. (2011) · PubMed · Cited by 77
Uncomplicated Urinary Tract Infections in Women
Foster, R. T. (2008) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2008.03.003 · Cited by 54
Poggio, T. V., TORRE, J. L. L., & Scodeller, E. A. (2006) · Canadian Journal of Microbiology · doi:10.1139/w06-065 · Cited by 50
Mapping pilicide anti-virulence effect in Escherichia coli, a comprehensive structure–activity study
Chorell, E., Pinkner, J. S., Bengtsson, C., Banchelin, T. S., Edvinsson, S., Linusson, A., Hultgren, S. J., & Almqvist, F. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.01.048 · Cited by 46
High Metabolic Potential May Contribute to the Success of ST131 Uropathogenic Escherichia coli
Gibreel, T. M., Dodgson, A. R., Cheesbrough, J., Bolton, F. J., Fox, A. J., & Upton, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01423-12 · Cited by 42
Cited by
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
Zowawi, H. M., Harris, P. N. A., Roberts, M. J., Tambyah, P. A., Schembri, M. A., Pezzani, M. D., Williamson, D. A., & Paterson, D. L. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.199 · Cited by 361
Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells
Bauckman, K. A., & Mysorekar, I. U. (2016) · Autophagy · doi:10.1080/15548627.2016.1160176 · Cited by 100
Human Urinary Composition Controls Antibacterial Activity of Siderocalin*
Shields-Cutler, R. R., Crowley, J. R., Hung, C. S., Stapleton, A. E., Aldrich, C. C., Marschall, J., & Henderson, J. P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645812 · Cited by 56
Metadata
- Authors
- Barber, A. E., Norton, J. P., Spivak, A. M., & Mulvey, M. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-03
- Volume
- 57
- Issue
- 5
- Pages
- 719-724
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2110901986
- Cited by
- 262
- References
- 37
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.